<DOC>
	<DOCNO>NCT00764413</DOCNO>
	<brief_summary>The Immunological system show diurnal rhythmicity . The Mediators enhance inflammation high level night . At time endogenous production cortisol low . We want study good effect treatment Methylprednisolone acute MS-attacks give nighttime . The effect measure relation neurological deficit function Kurtzkes Expanded Disability Status Score ( EDSS ) Multiple Sclerosis Functional Composite ( MSFC ) . We want see mean improvement EDSS great group receive treatment night oppose group get treatment daytime .</brief_summary>
	<brief_title>Chronotherapy Acute Multiple Sclerosis ( MS ) Attack</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Relapsing remit MS EDSSscore actual attack &lt; 6.0 Acute MSattack indication treatment steroid Symptoms &gt; 24 hour &lt; 4 week Age 18 year old Prior enrollment study Ongoing serious infection contraindication treatment steroid Pregnancy Medical situation ( prior acute disease ) treatment intravenous steroid short period time contraindicate favorable . Enhanced cognitive dysfunction Treatment p.o i.v steroid within 3 week prior date inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>EDSS</keyword>
	<keyword>methylprednisolone</keyword>
	<keyword>circadian rhythm</keyword>
	<keyword>MSFC</keyword>
</DOC>